COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead

Development COVID-19 vaccines in a record time has been an unprecedented global scientific achievement. However, the world has failed to ensure equitable access to what should have been a global public good. What options remain available to African countries to ensure immunization of their populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Massinga Loembé, Marguerite, Nkengasong, John N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276532/
https://www.ncbi.nlm.nih.gov/pubmed/34260880
http://dx.doi.org/10.1016/j.immuni.2021.06.017
_version_ 1783721920288522240
author Massinga Loembé, Marguerite
Nkengasong, John N.
author_facet Massinga Loembé, Marguerite
Nkengasong, John N.
author_sort Massinga Loembé, Marguerite
collection PubMed
description Development COVID-19 vaccines in a record time has been an unprecedented global scientific achievement. However, the world has failed to ensure equitable access to what should have been a global public good. What options remain available to African countries to ensure immunization of their populations and ultimately overcome the pandemic?
format Online
Article
Text
id pubmed-8276532
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82765322021-07-14 COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead Massinga Loembé, Marguerite Nkengasong, John N. Immunity Forum Development COVID-19 vaccines in a record time has been an unprecedented global scientific achievement. However, the world has failed to ensure equitable access to what should have been a global public good. What options remain available to African countries to ensure immunization of their populations and ultimately overcome the pandemic? Published by Elsevier Inc. 2021-07-13 2021-07-13 /pmc/articles/PMC8276532/ /pubmed/34260880 http://dx.doi.org/10.1016/j.immuni.2021.06.017 Text en © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Forum
Massinga Loembé, Marguerite
Nkengasong, John N.
COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead
title COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead
title_full COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead
title_fullStr COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead
title_full_unstemmed COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead
title_short COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead
title_sort covid-19 vaccine access in africa: global distribution, vaccine platforms, and challenges ahead
topic Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276532/
https://www.ncbi.nlm.nih.gov/pubmed/34260880
http://dx.doi.org/10.1016/j.immuni.2021.06.017
work_keys_str_mv AT massingaloembemarguerite covid19vaccineaccessinafricaglobaldistributionvaccineplatformsandchallengesahead
AT nkengasongjohnn covid19vaccineaccessinafricaglobaldistributionvaccineplatformsandchallengesahead

Ejemplares similares